Celogics
Quality Cells, Quality Research. Providing iPSC differentiation services for pharmaceutical research
3 employees · est. 2021 · Seattle, United States
Century Therapeutics, Inc
Advancing iPSC-derived cell therapies to transform care in autoimmune disease and cancer
119 employees · est. 2018 · Philadelphia, United States
Century Therapeutics, Inc is the older company (2021 vs 2018); Century Therapeutics, Inc is the larger of the two.
Side-by-Side Comparison
| Metric | Celogics | Century Therapeutics, Inc |
|---|---|---|
| Founded | ||
| Founded | 2021 | 2018 older |
| Headquarters | ||
| Headquarters | Seattle, United States | Philadelphia, United States |
| Employees | ||
| Employees | 3 | 119 larger |
| Industry | ||
| Industry | Biotechnology, Manufacturing | Biotechnology |
| Funding Stage | ||
| Funding Stage | Not tracked yet | Unknown |
| Total Funding | ||
| Total Funding | Not tracked yet | $655.00M |
| Funding Rounds | ||
| Funding Rounds | Not tracked yet | 6 |
| Services | ||
| Services | Custom Cardiomyocytes Development, High-Quality Human iPSC-derived Cell Products, Drug Development Acceleration, Disease Modeling Research | development of iPSC-derived cell therapies, manufacturing of allogeneic cell products, research in autoimmune and cancer therapies |
| Target Customers | ||
| Target Customers | Pharmaceutical Companies, Biotech Researchers, Medical Research Institutions, Disease Modelers | healthcare professionals, oncologists, endocrinologists, patients with autoimmune diseases, patients with type 1 diabetes |
| Taxonomy | ||
| Taxonomy | IPSC Differentiation, Pharmaceutical Research, Human Cell Culture, Research-use-only Cell Products, Drug Discovery, Drug Safety Screening, Disease Modeling, IPSC-derived Cells, Life Sciences, Functional Cell Models, Celo.Cells Brand, Biotechnology Joint Venture, Cell Manufacturing, Validated Data Provision, Cell Model Innovation | IPSC-derived Cell Therapies, Autoimmune Disease, Cancer Treatment, Allogeneic Therapies, Gene Editing, Protein Engineering, Technical Development, Manufacturing Capabilities, Therapeutic Innovation, Cell Therapy Platform, Immunotherapy, Biopharmaceutical, Regenerative Medicine |
| Website | ||
| Website | celogics.com | centurytx.com |
About Celogics
Celogics, founded in 2021, is carving a niche in the biotechnology and manufacturing sectors by pioneering advanced iPSC differentiation services tailored for pharmaceutical research. With the mission of enhancing the quality of human cell culture, Celogics aims to revolutionize research by producin...
About Century Therapeutics, Inc
Century Therapeutics, Inc is an emerging player in the biotechnology field, focused on advancing treatment solutions for autoimmune diseases and cancer. Founded in 2018 and headquartered in the United States, this company specializes in creating allogeneic, iPSC-derived cell therapies that leverage...
We will tell you when either one moves
BounceWatch watches Celogics and Century Therapeutics, Inc for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Celogics and Century Therapeutics,... — by email.
Frequently Asked Questions
Compare Celogics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Celogics on 4 Mar 2026, and Century Therapeutics, Inc on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.